Celularity, Inc. (CELU)
1.26
-0.07
(-5.26%)
USD |
NASDAQ |
Oct 16, 15:18
Celularity SG&A Expense (TTM) : 37.00M for March 31, 2026
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| March 31, 2026 | 37.00M |
| December 31, 2025 | 51.27M |
| September 30, 2025 | 52.26M |
| June 30, 2025 | 55.60M |
| March 31, 2025 | 58.88M |
| December 31, 2024 | 58.64M |
| September 30, 2024 | 55.38M |
| June 30, 2024 | 53.48M |
| March 31, 2024 | 50.40M |
| December 31, 2023 | 50.30M |
| September 30, 2023 | 56.59M |
| June 30, 2023 | 60.75M |
| March 31, 2023 | 63.50M |
| December 31, 2022 | 66.02M |
| September 30, 2022 | 60.15M |
| Date | Value |
|---|---|
| June 30, 2022 | 66.89M |
| March 31, 2022 | 80.18M |
| December 31, 2021 | 71.34M |
| September 30, 2021 | 64.11M |
| June 30, 2021 | 50.79M |
| March 31, 2021 | 21.93M |
| December 31, 2020 | 14.54M |
| September 30, 2020 | 9.935M |
| June 30, 2020 | 1.608M |
| March 31, 2020 | 1.723M |
| December 31, 2019 | 1.482M |
| September 30, 2019 | 0.1154M |
| June 30, 2019 | 0.1154M |
| March 31, 2019 | 0.0001M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Tenax Therapeutics, Inc. | 23.36M |
| Exicure, Inc. | 5.28M |
| Century Therapeutics, Inc. | 20.16M |
| Absci Corp. | 35.28M |
| Cardio Diagnostics Holdings, Inc. | 3.501M |